Pediatric Annals 2009-07-01

Immunotherapy for childhood warts.

David A Dasher, Craig N Burkhart, Dean S Morrell

Index: Pediatr. Ann. 38(7) , 373-9, (2009)

Full Text: HTML

Abstract

Treatment-resistant warts are a common and frustrating problem for patients, parents, and providers alike. No wart treatment is uniformly effective. Indeed, well-designed randomized controlled trials are sorely needed to establish the true efficacy of all wart therapies. Treatment should be tailored to each individual patient. Although none of the immunologically-based treatments listed above (see Table, page 377) is FDA-approved for warts, they provide the treating physician with options for patients with warts that are resistant to standard treatments.

Related Compounds

  • Dibutyl squarate

Related Articles:

Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.

2012-10-01

[Journal. of. Drugs in. Dermatology. 11(10) , 1228-30, (2012)]

Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.

2007-11-15

[Bioorg. Med. Chem. Lett. 17(22) , 6151-4, (2007)]

Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

2004-03-01

[Clin. Exp. Immunol. 135(3) , 398-408, (2004)]

Determination of in vivo dose response and allergen-specific T cells in subjects contact-sensitized to squaric acid dibutyl ester.

2008-01-01

[Dermatitis 19(2) , 95-9, (2008)]

Treatment of alopecia areata in children.

2009-07-01

[Pediatr. Ann. 38(7) , 388-95, (2009)]

More Articles...